| Jose M Saez, DO | |
|
36022 Tarpon Dr, Lewes, DE 19958-5058 | |
| (302) 430-0442 | |
| Not Available |
| Full Name | Jose M Saez |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 27 Years |
| Location | 36022 Tarpon Dr, Lewes, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316934417 | NPI | - | NPPES |
| 1000016712 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | C20005836 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fresenius Medical Care Milford | Milford, DE | Dialysis facility |
| Fresenius Medical Care Rehoboth | Rehoboth beach, DE | Dialysis facility |
| Fresenius Medical Care Southern Delaware, Llc | Bridgeville, DE | Dialysis facility |
| Bayhealth Hospital, Sussex Campus | Milford, DE | Hospital |
| Beebe Medical Center | Lewes, DE | Hospital |
| Nanticoke Memorial Hospital | Seaford, DE | Hospital |
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| We Care Nephrology Llc | 2961741277 | 3 |
News Archive
Advanced prostate cancer resistant to castration therapy appears to respond well to a combination of immune checkpoint blockades and treatments that target certain immune-busting cells commonly associated with poor patient prognosis and therapy resistance.
The Department of Veterans Affairs may need to pay heavily to treat veterans who have been adversely affected by Agent Orange. McClatchy/Beaufort (S.C.) Gazette report: "The cost of war - on veterans' health and taxpayer wallets - will loom a little larger in the new year when the Department of Veterans Affairs issues a final rule to claim adjudicators to presume three more diseases of Vietnam veterans, including heart disease, were caused by exposure to Agent Orange.
Celator Pharmaceuticals today announced that the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), operated by SAIC-Frederick (Frederick, Maryland), has agreed to conduct characterization studies to advance the development of the company's nanoparticle drug formulation technology.
New research shows that exposing a 3D human skin tissue model to extracts of medical device materials can detect the presence of sensitizers known to cause an allergic response on contact in some individuals. Conventional skin sensitization testing of medical devices relies on animal testing, whereas human skin models could replace animal methods, according to an article in the new journal Applied In Vitro Toxicology, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
› Verified 9 days ago
| Entity Name | We Care Nephrology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013487032 PECOS PAC ID: 2961741277 Enrollment ID: O20190305000357 |
News Archive
Advanced prostate cancer resistant to castration therapy appears to respond well to a combination of immune checkpoint blockades and treatments that target certain immune-busting cells commonly associated with poor patient prognosis and therapy resistance.
The Department of Veterans Affairs may need to pay heavily to treat veterans who have been adversely affected by Agent Orange. McClatchy/Beaufort (S.C.) Gazette report: "The cost of war - on veterans' health and taxpayer wallets - will loom a little larger in the new year when the Department of Veterans Affairs issues a final rule to claim adjudicators to presume three more diseases of Vietnam veterans, including heart disease, were caused by exposure to Agent Orange.
Celator Pharmaceuticals today announced that the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), operated by SAIC-Frederick (Frederick, Maryland), has agreed to conduct characterization studies to advance the development of the company's nanoparticle drug formulation technology.
New research shows that exposing a 3D human skin tissue model to extracts of medical device materials can detect the presence of sensitizers known to cause an allergic response on contact in some individuals. Conventional skin sensitization testing of medical devices relies on animal testing, whereas human skin models could replace animal methods, according to an article in the new journal Applied In Vitro Toxicology, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jose M Saez, DO 36022 Tarpon Dr, Lewes, DE 19958-5058 Ph: (302) 827-2316 | Jose M Saez, DO 36022 Tarpon Dr, Lewes, DE 19958-5058 Ph: (302) 430-0442 |
News Archive
Advanced prostate cancer resistant to castration therapy appears to respond well to a combination of immune checkpoint blockades and treatments that target certain immune-busting cells commonly associated with poor patient prognosis and therapy resistance.
The Department of Veterans Affairs may need to pay heavily to treat veterans who have been adversely affected by Agent Orange. McClatchy/Beaufort (S.C.) Gazette report: "The cost of war - on veterans' health and taxpayer wallets - will loom a little larger in the new year when the Department of Veterans Affairs issues a final rule to claim adjudicators to presume three more diseases of Vietnam veterans, including heart disease, were caused by exposure to Agent Orange.
Celator Pharmaceuticals today announced that the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), operated by SAIC-Frederick (Frederick, Maryland), has agreed to conduct characterization studies to advance the development of the company's nanoparticle drug formulation technology.
New research shows that exposing a 3D human skin tissue model to extracts of medical device materials can detect the presence of sensitizers known to cause an allergic response on contact in some individuals. Conventional skin sensitization testing of medical devices relies on animal testing, whereas human skin models could replace animal methods, according to an article in the new journal Applied In Vitro Toxicology, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
› Verified 9 days ago
Dr. George M. Kluchnik, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3555 Fax: 302-644-3560 | |
Amulya D Amirneni, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 17005 Old Orchard Rd, Lewes, DE 19958 Phone: 302-703-4025 | |
Dr. Steven A Calamita, MD Nephrology Medicare: Medicare Enrolled Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3300 | |
Dr. Maneshkumar F. Patel, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 400 Savannah Rd, Suite B, Lewes, DE 19958 Phone: 302-645-3555 | |
Robert C Deckmann, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 33663 Bayview Medical Dr, Unit 2, Lewes, DE 19958 Phone: 302-645-9325 Fax: 302-645-5214 | |
Harry J Anagnostakos, DO Nephrology Medicare: Not Enrolled in Medicare Practice Location: 400 Savannah Rd, Suite B, Lewes, DE 19958 Phone: 302-645-3555 Fax: 302-644-3560 | |
Dr. Carlton Boxhill, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1526 Savannah Rd, Lewes, DE 19958 Phone: 302-645-2244 Fax: 302-645-1173 |